Skip to main content
. Author manuscript; available in PMC: 2020 Jun 11.
Published in final edited form as: Pediatr Neurol. 2018 Dec 20;96:30–36. doi: 10.1016/j.pediatrneurol.2018.12.002

TABLE 2.

Prevalence of Symptoms/co-morbidities

Symptom Prevalence in SWS Population (n = 277) Prevalence in SWS Population Older Than 6 Years (n = 147)
Epilepsy 226 (81.6%) 122 (83.0%)
Learning disorder 116 (41.9%) 82 (55.8%)
Visual field cut 116 (41.9%) 71 (48.3%)
Hemiparesis 115 (41.5%) 55 (37.4%)
Headaches 109 (39.4%) 86 (58.5%)
Strokelike episode 105 (37.9%) 54 (36.7%)
Glaucoma surgery 96 (34.6%) 54 (36.7%)
Amblyopia 47 (17.0)% 30 (20.4%)
Intellectual disability 41 (14.8%) 30 (20.4%)
ADHD/ADD 39 (14.1%) 35 (23.8%)
Behavioral disorder 30 (10.8%) 26 (17.7%)
Symptomatic stroke 29 (10.5%) 16 (10.9%)
Brain surgery 25 (9.0%) 14 (9.5%)
Strabismus 22 (7.9%) 13 (8.8%)
Mood disorder 21 (7.6%) 20 (13.6%)
Thyroid disorder 20 (7.2%) 18 (12.2%)
Immune problem 12 (4.3%) 9 (6.1%)
Growth hormone deficiency 12 (4.3%) 7 (4.8%)
Autism spectrum disorder 8 (2.9%) 7 (4.8%)

Abbreviations:

ADHD/ADD = attention deficit hyperactivity disorder and/or attention deficit disorder

SWS = Sturge-Weber syndrome